Clinical Trials List
2020-05-12 - 2025-12-31
Phase III
Recruiting9
ICD-10C00.0
Malignant neoplasm of external upper lip
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9140.0
Malignant neoplasm of upper lip, vermilion border
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Yin Wu 無
- 劉奕廷 無
- Sen-Tien Tsai 無
- Kwang-Yu Chang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ling-Wei Wang 無
- Tien-Hua Chen Division of Hematology & Oncology
- Sheng-Yu Chen 無
- Mu-Hsin Chang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林倩伃 無
- Chi-Ting Liau 無
- Shu-Hang Ag 無
- Pei-Wei Huang 無
- Chia-Hsun Hsieh 無
- Li-Yu Lee 無
- 廖俊達 無
- Cheng-Lung Hsu 無
- Tzu-Chen Yen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
約39 participants
-
Global
約600 participants
